Tech Company Financing Transactions
Prellis Biologics Funding Round
Private investors participated in a $8.7 million capital raise for Prellis Biologics. The round was recorded on 3/28/2019.
Transaction Overview
Company Name
Announced On
3/28/2019
Transaction Type
Venture Equity
Amount
$8,741,168
Round
Undisclosed
Investors
Proceeds Purpose
Proceeds purposes were not disclosed. 11 investors participated in the offering. The amount may include options, warrants or other securities. Contact technology company for investment details, if applicable. Not an offer or solicitation for the sale of securities or debt. SEC regulatory filing.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
900 Indiana St.
San Francisco, CA 94107
USA
San Francisco, CA 94107
USA
Phone
Undisclosed
Website
Email Address
Not Recorded
Overview
At Prellis Biologics, we are driven by our vision of a world where functional human tissues can be created on demand in a laboratory setting.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Melanie Matheu
Controller
Matthew Niemiec
VP - Bus. Development
Diana Bogorodskaya
VP - Engineering
Erik Busby
Browse more venture capital transactions:
Prev: 3/28/2019: BurnAlong venture capital transaction
Next: 3/28/2019: MotoRefi venture capital transaction
Share this article
Where The Data Comes From
We do our best to document every notable VC transaction. VC investment data records reported here come from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs